European Commission President Ursula von der Leyen said on Friday that she is confident that the EU will reach a sufficient dose in July to achieve the goal of vaccination against Covid-19. 70% of the adult populationPartly thanks to the tremendous efforts of BioNTech and Pfizer to increase their production capacity.
In the statement of the community executive director within the framework of the visit to the Pfizer factory (Belgium) of Bayer (Puurs), the German also stated in detail that she hopes to sign the Pfizer contract “in the next few days.” Purchase 1.8 billion doses Serum developed by German laboratories and American pharmaceutical companies will be delivered between 2022 and 2023.
“Thanks to the tremendous efforts of BioNTech and Pfizer, I believe We will have enough dose Von der Lehn said, accompanied by Pfizer CEO Alz Bourla, BioNTech co-founder and medical business director Özlem Türeci and Belgian Prime Minister Alexander De Croo (Alexander De Croo), von der Lehn said: Vaccine 70% of adults in July.
The President of the European Commission stated that the EU vaccination campaign “On the right track” Although it encountered “difficulties” at the beginning, it has alleviated the situation because it has purchased a “broad product portfolio” of vaccines and the performance of “strong and reliable suppliers, such as BioNTech and Pfizer.”
Specifically, Von der Leyen pointed out that this week the EU has surpassed 150 million doses Member States, has managed 123 million member states.
The Germans said that Pfizer’s factory in Poole is Mass production first A vaccine based on messenger RNA technology (i.e. mRNA), Brussels is the most dedicated to this technology in the vaccination campaign.
In fact, the person in charge of the community executive officer has already proposed that she hopes to sign a new contract with the two pharmaceutical companies “in the next few days” and is expected to acquire the company. 1.8 billion doses It will be distributed to Member States between 2022 and 2023 to cover booster immunization, needs before the emergence of new variants, and vaccinations for minors.
“This Consolidate the leadership of the European Union Von der Leyen emphasized that he also celebrated that the European Medicines Agency (EMA) approved the green light on Friday to increase the production capacity of the Belgian factory in Puls by 20%.
The CEO of Pfizer has made it clear that Improvement of the production process At the factory, they have reduced the average manufacturing time from about 100 days to 60 days. Bourla also noted that the company is “surpassing” its delivery commitments to European Union countries.
“We will provide 250 million doses By the end of the second quarter, it was four times that of the first quarter,” he emphasized that this is in line with the recent agreement reached by the European Commission, and later added that starting in May, the company is expected to be able to produce about 100 million doses at the Belgian plant. Every month.
Overall, the current agreement between Pfizer and community executives takes into account 600 million doses Sell its Covid-19 vaccine to EU countries before the end of the year.
For him, Turési praised the power of public-private partnerships to respond to these types of health emergencies and ensured that another lesson learned from this pandemic is: “Technology can make a difference”.